Melissa Esgro2021-04-08T11:28:45-04:00 Pharmaceutical Sales Strategies Post COVID-19: The Benefits of Virtual Engagement
Melissa Esgro2021-03-11T14:36:23-05:00 Understanding the CMS Best Price Rule and Its Impact to Co-Pay Programs
cpalacio2021-03-07T06:38:35-05:00 Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs
cpalacio2021-03-07T06:38:48-05:00 The Evidence is In: Integrated Hub and Co-Pay Services Really Do Yield Better Results
cpalacio2021-03-07T06:39:14-05:00 Using Digital Engagement to Solve Pain Points Along the Patient Journey
cpalacio2021-03-07T06:40:56-05:00 Understanding Implications of Proposed Best Price Revisions for Manufacturer Assistance Programs
Kevin Brasco2021-03-07T06:41:56-05:00 Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected?
Kevin Brasco2021-03-07T06:42:52-05:00 Co-Pay Accumulator Programs: New Battle or Just Another Front in a Never-Ending War?
Kevin Brasco2021-03-07T06:43:05-05:00 Accumulator Adjustment Programs: What They Are, What They Are Not, and How Should an Affected Health Plan Member Respond?
Kevin Brasco2021-03-07T06:44:17-05:00 Co-Pay Accumulators: Measuring the Impact on Patients and Pharmaceutical Manufacturers
Kevin Brasco2021-03-07T06:44:13-05:00 Examining the Financial Implications of Co-Pay Accumulator Plans
Kevin Brasco2021-03-07T06:44:43-05:00 Integrating Engagement and Adherence Solutions with Affordability Programs
Kevin Brasco2021-03-07T06:44:54-05:00 The Benefits of Integrating Adherence and Engagement Into Co-Pay and Hub Programs
Kevin Brasco2021-03-07T06:46:02-05:00 Leveraging Virtual Engagement to Further HCP Access and Drive Brand Reach
Kevin Brasco2021-03-07T06:47:09-05:00 The New Sales Model: Virtual Engagement in the Time of COVID-19
TC Resources2021-03-07T06:46:59-05:00 The Rise of Co-Pay Accumulator Programs: Are Your Brand’s Patients at Risk?
